Product Categories
| Country: | China |
|---|---|
| Tel: | 0311-67591193 |
| Mobile: | 15933619867 |
| E-mail: | Sales02@dingminpharma.com |
| QQ: | 2786999724 |
| Skype: | Chat Now! |
| Address: | NO.52 ZHAIYING SOUTH STREET |
|
Shijiazhuang Dingmin Pharmaceutical Sciences Co., LTD. founded in 2014, is a professional company focusing on the research and development, production, sales and technical services of pharmaceutical raw materials and intermediates. It is an internationally recognizedpharmaceutical contract development and manufacturing organization (CDMO) in enabling our global clients to optimize drug development and manufacturing. We provide customer development and manufacturing services for small molecule, Large molecule and Gene and Cell Therapies from pre-clinical to commercialization.Product lines involve anti-AIDS, hepatitis, diabetes, cancer, analgesia,anti-heart failure, blood lipid, insomnia, epilepsy, anti-flu, anti-allergy and other major disease treatment fields.
The factory is located in the Pharmaceutical Biological Park of Shijiazhuang Economic and Technological Development Zone, and carries out production management in strict accordance with GMP concept.
In order to maintain continuous innovation and R&D capabilities, the company adheres tomarket demand-oriented, maintains long-term and close cooperation with a number of domestic scientific research institutions and universities, establishes joint laboratories, and relies on them as technology, thus ensuring that the quantity, speed and quality of new product development to production transformation are at the leading level in China, and the products are exported to Europe. America, Asia and other countries and regions.
Having upholding the " integrity, profession , innovation, win-win" as business philosophy,we believe that we are able to be stronger and stronger because of the excellent quality, favorable price and full-hearted service. We would like to sincerely welcome friends from all sectors toco-create a brilliant tomorrow together.
|
|
| Product Name | MF | CAS | Details |
|---|
| 2-Cyclohexen-1-one | C6H8O | 930-68-7 | Details |
| Sorafenib tosylate | C21H16ClF3N4O3.C7H8O3S | 475207-59-1 | Details |
| Sunitinib malate | C26H33FN4O7 | 341031-54-7 | Details |
| Axitinb | C22H18N4OS | 319460-85-0 | Details |
| Apalutamide | C21H15F4N5O2S | 956104-40-8 | Details |
| Erlotinib hydrochloride | C22H24ClN3O4 | 183319-69-9 | Details |
| 1-Piperidinecarboxylic acid, 4-(4-iodo-1H-pyrazol-1-yl)-, 1,1-dimethylethyl ester | C13H20IN3O2 | 877399-73-0 | Details |
| 5-Formyl-2,4-dimethyl-1H-pyrrole-3-carboxylic acid | C8H9NO3 | 253870-02-9 | Details |
| 5-Amino-3-(trifluromethyl) picolinonitrile | C7H4F3N3 | 573762-62-6 | Details |
| Ethyl 5-formyl-2,4-dimethyl-1H-pyrrole-3-carboxylate | C10H13NO3 | 2199-59-9 | Details |
| 2-Mercapto-N-Methylbenzamide | C8H9NOS | 20054-45-9 | Details |
| Lenvatinib mesylate | C22H23ClN4O7S | 857890-39-2 | Details |
| 4-amino-3-chlorophenol | C6H6ClNO | 17609-80-2 | Details |
| Tofacitinib Citrate | C16H20N6O.C6H8O7 | 540737-29-9 | Details |
| 4-Chloropyrrolo[2,3-d]pyrimidine | C6H4ClN3 | 3680-69-1 | Details |
| Nintedanib | C31H33N5O4 | 656247-17-5 | Details |
| N-(4-aminophenyl)-n,4-dimethyl-1-piperazineacetamide | C14H22N4O | 262368-30-9 | Details |
| 2-chloro-N-methyl-N-(4-nitrophenyl)acetamide | C9H9ClN2O3 | 2653-16-9 | Details |
| 2-bromo-N-methyl-N-(4-nitrophenyl)acetamide | C9H9BrN2O3 | 23543-31-9 | Details |
| N-methyl-4-nitro-Benzenamine | C7H8N2O2 | 100-15-2 | Details |
| Abiraterone | C24H31NO | 154229-19-3 | Details |
| 17-Iodoandrosta-5,16-dien-3β-acetate ester | C21H29IO2 | 114611-53-9 | Details |
| Methyl 2-((1H-pyrrolo[2,3-b]pyridin-5-yl)oxy)-4-fluorobenzoate | C15H11FN2O3 | 1235865-75-4 | Details |
| 5-isothiocyanato-3-(trifluoromethyl)picolinonitrile | C8H2F3N3S | 951753-87-0 | Details |
| 6,7-bis-(2-Methoxyethoxy)-quinazolin-4(3h)-one | C14H18N2O5 | 179688-29-0 | Details |
| 4-(4-Aminophenoxy)-N-methylpicolinamide | C13H13N3O2 | 284462-37-9 | Details |
| Tert-butyl 4-[4-[6-amino-5-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]pyridin-3-yl]pyrazol-1-yl]piperidine-1-carboxylate | C26H30Cl2FN5O3 | 877399-51-4 | Details |
| 5-Fluoro-1,3-dihydro-2H-indol-2-one | C8H6FNO | 56341-41-4 | Details |
| 6-Iodo-1H-indazole | C7H5IN2 | 261953-36-0 | Details |
| 1,4-Dihydro-7-methoxy-4-oxo-6-quinolinecarbonitrile | C11H8N2O2 | 417721-15-4 | Details |
| Tofacitinb | C16H20N6O | 477600-75-2 | Details |
| (3R,4R)-1-Benzyl-N,4-diMethylpiperidin-3-aMine dihydrochloride | C14H23ClN2 | 1062580-52-2 | Details |
| (2,5-dioxopyrrolidin-1-yl) 2-cyanoacetate | C7H6N2O4 | 56657-76-2 | Details |
| Nintedanib ethanesulfonate | C33H39N5O7S | 656247-18-6 | Details |
| Methyl 2-oxoindole-6-carboxylate | C10H9NO3 | 14192-26-8 | Details |
| N-methyl-2-(4-methylpiperazin-1-yl)-N-(4-nitrophenyl)acetamide | C14H20N4O3 | 1139453-98-7 | Details |
| Methyl 4-(di(methoxycarbonyl)methyl)-3-nitrobenzoate | C13H13NO8 | 1160293-27-5 | Details |
| Abiraterone acetate | C26H33NO2 | 154229-18-2 | Details |
| 17-Iodoandrosta-5,16-dien-3β-ol | C19H27IO | 32138-69-5 | Details |
| 5-Hydroxy-7-azaindole | C7H6N2O | 98549-88-3 | Details |
| 1-((4'-chloro-5,5-dimethyl-3,4,5,6-tetrahydro-[1,1'-biphenyl]-2-yl)methyl) piperazine | C19H27ClN2 | 1228780-72-0 | Details |
| 2-(4-((5,6-diphenylpyrazin-2-yl)(isopropyl)amino)butoxy)acetic acid | C25H29N3O3 | 475085-57-5 | Details |
| 4-(Isopropylamino)butanol | C7H17NO | 42042-71-7 | Details |
| Rimegepant | C28H28F2N6O3 | 1289023-67-1 | Details |
| (6S,9R)-6-(2,3-Difluorophenyl)-6,7,8,9-tetrahydro-9-[[tris(1-methylethyl)silyl]oxy]-5H-cyclohepta[b]pyridin-5-one | C25H33F2NO2Si | 1190363-46-2 | Details |
| 2,4-di-tert-butyl-5-(4-oxo-1,4-dihydroquinoline-3-carboxamido)phenyl methyl carbonate | C26H30N2O5 | 1246213-45-5 | Details |
| 6-chloro-5-methylpyridin-2-amine | C6H7ClN2 | 442129-37-5 | Details |
| (R)-(2,2-dimethyl-1,3-dioxolan-4-yl)methanol | C6H12O3 | 14347-78-5 | Details |
| Carbamic acid,N-[(1S)-2,3-dihydro-4-[(hydroxyamino)iminomethyl]-1H-inden-1-yl]-N-[2-[[(1,1-dimethylethyl)dimethylsilyl]oxy]ethyl]-, 1,1-dimethylethyl ester | C23H39N3O4Si | 1306763-62-1 | Details |
| N-(1-hydroxy-2-(hydroxymethyl)-4-(4-octylphenyl)butan-2-yl)acetamide | C21H35NO3 | 249289-10-9 | Details |
| Darolutamide | C19H19ClN6O2 | 1297538-32-9 | Details |
| 5-Acetyl-1(2)H-pyrazole-3-carboxylic acid ethyl ester | C8H10N2O3 | 37622-89-2 | Details |
| Ozanimod | C23H24N4O3 | 1306760-87-1 | Details |
| Siponimod fumarate | C33H39F3N2O7 | 1234627-85-0 | Details |
| 4-((5,6-diphenylpyrazin-2-yl)(isopropyl)amino)butan-1-ol | C23H27N3O | 475086-75-0 | Details |
| 3-Fluoro-4-Methylphenylisothiocyanate | C9H3F3N2S | 143782-23-4 | Details |
| Rimegepant Sulfate | C28H30F2N6O7S | 1374024-48-2 | Details |
| 3-(6-Amino-3-methyl-pyridin-2-yl)-benzoicacidtert-butylester | C17H20N2O2 | 1083057-14-0 | Details |
| (((2,2-dimethylbut-3-yn-1-yl)oxy)methyl)benzene | C13H16O | 1092536-54-3 | Details |
| (E)-4-(1-(((4-cyclohexyl-3-(trifluoromethyl)benzyl)oxy)imino)ethyl)-2-ethylbenzaldehyde | C25H28F3NO2 | 1230487-01-0 | Details |
| 3-cyano-4-isopropoxybenzoic acid | C11H11NO3 | 258273-31-3 | Details |
| N-[1,1-Bis[(acetyloxy)methyl]-3-phenylpropyl]acetamide | C17H23NO5 | 162359-95-7 | Details |
| 5-Acetyl-1H-Pyrazole-3-carboxylic acid | C6H6N2O3 | 1297537-45-1 | Details |
| Ozanimod Hcl | C23H25ClN4O3 | 1618636-37-5 | Details |
| 5-Chloro-2,3-diphenylpyrazine | C16H11ClN2 | 41270-66-0 | Details |
| N-[3-Fluoro-4-[(Methylamino)Carbonyl]Phenyl]-2-Methylalanine Methyl Ester | C13H17FN2O3 | 1332524-01-2 | Details |
| 7,8-dihydro-5H-cyclohepta[b]pyridine-5,9(6H)-dione | C10H9NO2 | 39713-40-1 | Details |
| 4-oxo-1,4-dihydroquinoline-3-carboxylic acid | C10H7NO3 | 13721-01-2 | Details |
| 1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarbonitrile | C11H7F2NO2 | 862574-87-6 | Details |
| 2-[1-(benzyloxy)-2-methylpropan-2-yl]-6-fluoro-5-nitro-1H-indole | C19H19FN2O3 | 1638771-94-4 | Details |
| (R)-tert-butyl (4-cyano-2,3-dihydro-1H-inden-1-yl)carbamate | C15H18N2O2 | 1306763-31-4 | Details |
| Fingolimod | C19H33NO2 | 162359-55-9 | Details |
| 2-acetamido-2-(4-octanoylphenethyl)propane-1,3-diyl diacetate | C25H37NO6 | 249289-07-4 | Details |
| (S)-4-(1-(2-aminopropyl)-1H-pyrazol-3-yl)-2-chlorobenzonitrile | C13H13ClN4 | 1297537-41-7 | Details |
| Tezacaftor (VX-661) | C26H27F3N2O6 | 1152311-62-0 | Details |
| O-(4-cyclohexyl-3-(trifluoromethyl)benzyl)hydroxylamine | C14H18F3NO | 800379-62-8 | Details |
| 2-Bromo-5,6-diphenylpyrazine | C16H11BrN2 | 243472-70-0 | Details |
| N-[3-Fluoro-4-[(Methylamino)Carbonyl]Phenyl]-2-Methylalanine | C12H15FN2O3 | 1289942-66-0 | Details |
| 1,3-Dihydro-1-[1-(1H-imidazol-1-ylcarbonyl)-4-piperidinyl]-2H-imidazo[4,5-b]pyridin-2-one | C15H16N6O2 | 1373116-06-3 | Details |
| 1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropane-1-carboxylic acid | C11H8F2O4 | 862574-88-7 | Details |
| 2-bromo-5-fluoro-4-nitroaniline | C6H4BrFN2O2 | 952664-69-6 | Details |
| 2-acetamido-2-(4-octylphenethyl)propane-1,3-diyl diacetate | C25H39NO5 | 162358-09-0 | Details |
| 2-Chloro-4-(1H-pyazol-3-yl)benzonitrile | C10H6ClN3 | 1297537-37-1 | Details |
| Selexipag | C26H32N4O4S | 475086-01-2 | Details |
| Siponimod | C29H35F3N2O3 | 1230487-00-9 | Details |
| Fingolimod Hcl | C19H34ClNO2 | 162359-56-0 | Details |
| 1-oxo-2,3-dihydro-1H-indene-4-carbonitrile | C10H7NO | 60899-34-5 | Details |
| 1-(3-ethyl-4-(hydroxymethyl)phenyl)ethan-1-one | C11H14O2 | 1378888-43-7 | Details |
| Ivacaftor (VX-770) | C24H28N2O3 | 873054-44-5 | Details |
| 5-amino-2,4-di-tert-butylphenol hydrochloride | C14H23NO | 873055-58-4 | Details |
| Lumacaftor (VX-809) | C24H18F2N2O5 | 936727-05-8 | Details |
| Erlotinib | C22H23N3O4 | 183321-74-6 | Details |
| Pazopanib HCL | C21H24ClN7O2S | 635702-64-6 | Details |
| 4-Chloro-N-Methylpyridine -2-Carboxamide | C7H7ClN2O | 220000-87-3 | Details |
| 4,5-bis(2-methoxyethoxy)-2-nitrobenzonitrile | C13H16N2O6 | 236750-65-5 | Details |
| 4-Chloro-3-(trifluoromethyl)phenyl isocyanate | C8H3ClF3NO | 327-78-6 | Details |
| (R)-5-bromo-3-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)pyridin-2-amine | C13H10BrCl2FN2O | 877399-00-3 | Details |
| Crizotinib | C21H22Cl2FN5O | 877399-52-5 | Details |
| 3-Amino-6-methylbenzenesulfonamide | C7H10N2O2S | 6973-09-7 | Details |
| 2,3-dimethyl-2H-indazol-6-amine hydrochloride | C9H12ClN3 | 635702-60-2 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 | ||||